The contribution of the systolic and diastolic components for the diagnosis of arterial hypertension under the 2017 ACC/AHA Guideline and metabolic heterogeneity among individuals with Stage 1 hypertension (2020)
- Authors:
- USP affiliated authors: SANTOS FILHO, RAUL DIAS DOS - FM ; BITTENCOURT, MÁRCIO SOMMER - HU
- Unidades: FM; HU
- DOI: 10.1111/jch.13907
- Subjects: GUIAS; HIPERTENSÃO; PRESSÃO SANGUÍNEA; DOENÇAS METABÓLICAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of clinical hypertension
- ISSN: 1524-6175
- Volume/Número/Paginação/Ano: v. 22, n. 7, p. 1192-1199, 2020
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
CESENA, Fernando H. Y et al. The contribution of the systolic and diastolic components for the diagnosis of arterial hypertension under the 2017 ACC/AHA Guideline and metabolic heterogeneity among individuals with Stage 1 hypertension. Journal of clinical hypertension, v. 22, n. 7, p. 1192-1199, 2020Tradução . . Disponível em: https://doi.org/10.1111/jch.13907. Acesso em: 26 dez. 2025. -
APA
Cesena, F. H. Y., Nary, F. C., Santos, R. de P., & Bittencourt, M. S. (2020). The contribution of the systolic and diastolic components for the diagnosis of arterial hypertension under the 2017 ACC/AHA Guideline and metabolic heterogeneity among individuals with Stage 1 hypertension. Journal of clinical hypertension, 22( 7), 1192-1199. doi:10.1111/jch.13907 -
NLM
Cesena FHY, Nary FC, Santos R de P, Bittencourt MS. The contribution of the systolic and diastolic components for the diagnosis of arterial hypertension under the 2017 ACC/AHA Guideline and metabolic heterogeneity among individuals with Stage 1 hypertension [Internet]. Journal of clinical hypertension. 2020 ; 22( 7): 1192-1199.[citado 2025 dez. 26 ] Available from: https://doi.org/10.1111/jch.13907 -
Vancouver
Cesena FHY, Nary FC, Santos R de P, Bittencourt MS. The contribution of the systolic and diastolic components for the diagnosis of arterial hypertension under the 2017 ACC/AHA Guideline and metabolic heterogeneity among individuals with Stage 1 hypertension [Internet]. Journal of clinical hypertension. 2020 ; 22( 7): 1192-1199.[citado 2025 dez. 26 ] Available from: https://doi.org/10.1111/jch.13907 - Association between Thyroid-Stimulating Hormone Levels and Non-Alcoholic Fatty Liver Disease Is Not Independent from Metabolic Syndrome Criteria
- The expected cardiovascular benefit of plasma cholesterol lowering with or without LDL-C targets in healthy individuals at higher cardiovascular risk
- Comparing the expected benefit of plasma cholesterol reduction with or without LDL-C targets in a high-risk, healthy population
- Cardiovascular risk and statin eligibility in primary prevention: a comparison between the Brazilian and the AHA/ACC Guidelines
- Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study
- Association between clinical factors and self-underestimation of cardiovascular risk in subjects submitted to a routine health evaluation
- Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis
- The obesity paradox on the treadmill: relationship between body mass index and positive exercise stress tests
- Cardiovascular risk stratification and statin eligibility based on the Brazilian vs. North American Guidelines on blood cholesterol management
- Does physical activity influence the association between depressive symptoms and low-grade inflammation in adults?: a study of 8,048 adults
Informações sobre o DOI: 10.1111/jch.13907 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
